Literature DB >> 25977565

Reduction of Mitochondria-Endoplasmic Reticulum Interactions by Acetylcholine Protects Human Umbilical Vein Endothelial Cells From Hypoxia/Reoxygenation Injury.

Xi He1, Xue-Yuan Bi1, Xing-Zhu Lu1, Ming Zhao1, Xiao-Jiang Yu1, Lei Sun1, Man Xu1, W Gil Wier1, Wei-Jin Zang2.   

Abstract

OBJECTIVE: We explored the role of endoplasmic reticulum (ER)-mitochondria Ca(2+) cross talk involving voltage-dependent anion channel-1 (VDAC1)/glucose-regulated protein 75/inositol 1,4,5-trisphosphate receptor 1 complex and mitofusin 2 in endothelial cells during hypoxia/reoxygenation (H/R), and investigated the protective effects of acetylcholine. APPROACH AND
RESULTS: Acetylcholine treatment during reoxygenation prevented intracellular and mitochondrial Ca(2+) increases and alleviated ER Ca(2+) depletion during H/R in human umbilical vein endothelial cells. Consequently, acetylcholine enhanced mitochondrial membrane potential and inhibited proapoptotic cascades, thereby reducing cell death and preserving endothelial ultrastructure. This effect was likely mediated by the type-3 muscarinic acetylcholine receptor and the phosphatidylinositol 3-kinase/Akt pathway. In addition, interactions among members of the VDAC1/glucose-regulated protein 75/inositol 1,4,5-trisphosphate receptor 1 complex were increased after H/R and were associated with mitochondrial Ca(2+) overload and cell death. Inhibition of the partner of the Ca(2+) channeling complex (VDAC1 siRNA) or a reduction in ER-mitochondria tethering (mitofusin 2 siRNA) prevented the increased protein interaction within the complex and reduced mitochondrial Ca(2+) accumulation and subsequent endothelial cell death after H/R. Intriguingly, acetylcholine could modulate ER-mitochondria Ca(2+) cross talk by inhibiting the VDAC1/glucose-regulated protein 75/inositol 1,4,5-trisphosphate receptor 1 complex and mitofusin 2 expression. Phosphatidylinositol 3-kinase siRNA diminished acetylcholine-mediated inhibition of mitochondrial Ca(2+) overload and VDAC1/glucose-regulated protein 75/inositol 1,4,5-trisphosphate receptor 1 complex formation induced by H/R.
CONCLUSIONS: Our data suggest that ER-mitochondria interplay plays an important role in reperfusion injury in the endothelium and may be a novel molecular target for endothelial protection. Acetylcholine attenuates both intracellular and mitochondrial Ca(2+) overload and protects endothelial cells from H/R injury, presumably by disrupting the ER-mitochondria interaction.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  acetylcholine; calcium; endothelial cells; mitochondria; reperfusion injury

Mesh:

Substances:

Year:  2015        PMID: 25977565     DOI: 10.1161/ATVBAHA.115.305469

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  13 in total

1.  Acetylcholine ameliorates endoplasmic reticulum stress in endothelial cells after hypoxia/reoxygenation via M3 AChR-AMPK signaling.

Authors:  Xueyuan Bi; Xi He; Man Xu; Ming Zhao; Xiaojiang Yu; Xingzhu Lu; Weijin Zang
Journal:  Cell Cycle       Date:  2015-06-11       Impact factor: 4.534

2.  Absinthin, an agonist of the bitter taste receptor hTAS2R46, uncovers an ER-to-mitochondria Ca2+-shuttling event.

Authors:  Maria Talmon; Silvia Rossi; Dmitry Lim; Federica Pollastro; Gioele Palattella; Federico A Ruffinatti; Patrizia Marotta; Renzo Boldorini; Armando A Genazzani; Luigia G Fresu
Journal:  J Biol Chem       Date:  2019-06-27       Impact factor: 5.157

3.  Inhibition of the mitochondrial unfolded protein response by acetylcholine alleviated hypoxia/reoxygenation-induced apoptosis of endothelial cells.

Authors:  Man Xu; Xueyuan Bi; Xi He; Xiaojiang Yu; Ming Zhao; Weijin Zang
Journal:  Cell Cycle       Date:  2016-04-25       Impact factor: 4.534

Review 4.  Apoptosis in resistance arteries induced by hydrogen peroxide: greater resilience of endothelium versus smooth muscle.

Authors:  Rebecca L Shaw; Charles E Norton; Steven S Segal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-02-19       Impact factor: 4.733

5.  Acetylcholine reduces palmitate-induced cardiomyocyte apoptosis by promoting lipid droplet lipolysis and perilipin 5-mediated lipid droplet-mitochondria interaction.

Authors:  Qing Wu; Ming Zhao; Xi He; Runqing Xue; Dongling Li; Xiaojiang Yu; Shengpeng Wang; Weijin Zang
Journal:  Cell Cycle       Date:  2021-08-23       Impact factor: 5.173

6.  Vagal nerve stimulation improves mitochondrial dynamics via an M3 receptor/CaMKKβ/AMPK pathway in isoproterenol-induced myocardial ischaemia.

Authors:  Run-Qing Xue; Lei Sun; Xiao-Jiang Yu; Dong-Ling Li; Wei-Jin Zang
Journal:  J Cell Mol Med       Date:  2016-08-05       Impact factor: 5.310

7.  Hypoxia induces miR-153 through the IRE1α-XBP1 pathway to fine tune the HIF1α/VEGFA axis in breast cancer angiogenesis.

Authors:  Huichun Liang; Ji Xiao; Zhongmei Zhou; Jiao Wu; Fei Ge; Zongcheng Li; Hailin Zhang; Jian Sun; Fubing Li; Rong Liu; Ceshi Chen
Journal:  Oncogene       Date:  2018-01-25       Impact factor: 9.867

8.  Progerin accumulation in nucleus pulposus cells impairs mitochondrial function and induces intervertebral disc degeneration and therapeutic effects of sulforaphane.

Authors:  Xiaolong Xu; Di Wang; Chao Zheng; Bo Gao; Jing Fan; Pengzhen Cheng; Baohua Liu; Liu Yang; Zhuojing Luo
Journal:  Theranostics       Date:  2019-04-12       Impact factor: 11.556

9.  A Novel Ruthenium-based Molecular Sensor to Detect Endothelial Nitric Oxide.

Authors:  Achini K Vidanapathirana; Benjamin J Pullen; Run Zhang; MyNgan Duong; Jarrad M Goyne; Xiaozhou Zhang; Claudine S Bonder; Andrew D Abell; Christina A Bursill; Stephen J Nicholls; Peter J Psaltis
Journal:  Sci Rep       Date:  2019-02-08       Impact factor: 4.379

10.  Protective Effects of Rhodiola Crenulata Extract on Hypoxia-Induced Endothelial Damage via Regulation of AMPK and ERK Pathways.

Authors:  Pi-Kai Chang; I-Chuan Yen; Wei-Cheng Tsai; Tsu-Chung Chang; Shih-Yu Lee
Journal:  Int J Mol Sci       Date:  2018-08-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.